Postoperative Course and Recurrence of Chronic Subdural Hematoma.
10.3340/jkns.2010.48.6.518
- Author:
Hyuck Jin OH
1
;
Kyeong Seok LEE
;
Jae Jun SHIM
;
Seok Mann YOON
;
Il Gyu YUN
;
Hack Gun BAE
Author Information
1. Department of Neurosurgery, Soonchunhyang University Cheonan Hospital, Cheonan, Korea. ksleens@sch.ac.kr
- Publication Type:Original Article
- Keywords:
Chronic subdural hematoma;
Craniocerebral trauma;
Diagnosis;
Recurrence;
Risk Factors
- MeSH:
Aged;
Craniocerebral Trauma;
Hematoma;
Hematoma, Subdural, Chronic;
Humans;
Medical Records;
Membranes;
Recurrence;
Retrospective Studies;
Risk Factors
- From:Journal of Korean Neurosurgical Society
2010;48(6):518-523
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Chronic subdural hematoma (CSDH) is known to have a significant recurrence rate. There are different criteria defining the recurrence of CSDH. We evaluated the postoperative course of CSDH and tried to propose the reasonable criteria of recurrence. METHODS: We retrospectively examined the medical records and pre- and postoperative CT scans of 149 consecutive patients who underwent surgery from January 2005 to December 2009. Diagnosis was confirmed by CT scanning or MRI. The postoperative courses were either resolved or recurrent. The resolved CSDH was one of the three types; early resolution, delayed resolution, or late resolution. The recurrent CSDH was one of the four types; recurrence without resolution, early recurrence after resolution, late recurrence after resolution, or recurrent-and-resolved type. RESULTS: The CSDH was resolved within 30 days after surgery in 58 (39%) patients, between 1 to 3 months in 62 (42%), and after 3 months in 11 (7%) patients. The CSDH was recurred in 18 (12%) patients. Late resolution or recurrence was more common in the aged. The recurrent hematoma was seen on the same side in 11 patients, on the different side in 7 patients. Recurrence was significantly more common in the thick hematomas. CONCLUSION: For a working criteria of the recurrence of CSDH, we propose the early recurrence as return of symptoms or reaccumulation of the hematoma after a surgery within 3 months regardless of the location, amount or repeated operations. The late recurrence can be defined as reappearance or enlargement of a liquefied hematoma within the cranial cavity surrounded by the membranes or persistent CSDH beyond 3 months after surgery.
